Detail akcie Invo Fertility Rg online

Business Summary: INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services company focused on the fertility marketplace and expanding access to assisted reproductive technology (ART) care for patients in need. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. It focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. It has two operational INVO Centers in the United States and one IVF clinic. It is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, INVO Fertility Inc revenues increased 8% to $5.3M. Net loss before extraordinary items increased from $5.5M to $23.3M. Revenues reflect Product Revenue increase from $83K to $1.9M. Higher net loss reflects Loss from debt extinguishment increase from $40K to $1.6M (expense), Selling/General/Admin. Expense increase of 23% to $6.9M (expense).